Working… Menu

A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia (EMPACTA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04372186
Recruitment Status : Active, not recruiting
First Posted : May 1, 2020
Last Update Posted : July 15, 2021
Information provided by (Responsible Party):
Genentech, Inc.